BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 28115492)

  • 1. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
    Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy.
    Gasia MF; Ghosh S; Panaccione R; Ferraz JG; Kaplan GG; Leung Y; Novak KL; Seow CH; Iacucci M
    Clin Gastroenterol Hepatol; 2016 May; 14(5):704-12.e4. PubMed ID: 26804384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
    Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy.
    Hlavaty T; Huorka M; Koller T; Zita P; Kresanova E; Rychly B; Toth J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):680-9. PubMed ID: 21602687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Carballal S; Maisterra S; López-Serrano A; Gimeno-García AZ; Vera MI; Marín-Garbriel JC; Díaz-Tasende J; Márquez L; Álvarez MA; Hernández L; De Castro L; Gordillo J; Puig I; Vega P; Bustamante-Balén M; Acevedo J; Peñas B; López-Cerón M; Ricart E; Cuatrecasas M; Jimeno M; Pellisé M;
    Gut; 2018 Jan; 67(1):70-78. PubMed ID: 27612488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial.
    Bisschops R; Bessissow T; Joseph JA; Baert F; Ferrante M; Ballet V; Willekens H; Demedts I; Geboes K; De Hertogh G; Vermeire S; Rutgeerts P; Van Assche G
    Gut; 2018 Jun; 67(6):1087-1094. PubMed ID: 28698230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
    Azizi S; Al-Rubaye H; Turki MAA; Siddiqui MRS; Shanmuganandan AP; Ehsanullah B; Brar R; Abulafi AM
    Int J Surg; 2018 Apr; 52():180-188. PubMed ID: 29462738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.
    Dekker E; van den Broek FJ; Reitsma JB; Hardwick JC; Offerhaus GJ; van Deventer SJ; Hommes DW; Fockens P
    Endoscopy; 2007 Mar; 39(3):216-21. PubMed ID: 17385106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-enhanced endoscopy is critical in the surveillance of patients with colonic IBD.
    Subramanian V; Bisschops R
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):393-403. PubMed ID: 24975530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial.
    Alexandersson B; Hamad Y; Andreasson A; Rubio CA; Ando Y; Tanaka K; Ichiya T; Rezaie R; Schmidt PT
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2101-2107. PubMed ID: 32353535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.
    Neumann H; Vieth M; Langner C; Neurath MF; Mudter J
    World J Gastroenterol; 2011 Jul; 17(27):3184-91. PubMed ID: 21912466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.
    Watanabe T; Ajioka Y; Mitsuyama K; Watanabe K; Hanai H; Nakase H; Kunisaki R; Matsuda K; Iwakiri R; Hida N; Tanaka S; Takeuchi Y; Ohtsuka K; Murakami K; Kobayashi K; Iwao Y; Nagahori M; Iizuka B; Hata K; Igarashi M; Hirata I; Kudo SE; Matsumoto T; Ueno F; Watanabe G; Ikegami M; Ito Y; Oba K; Inoue E; Tomotsugu N; Takebayashi T; Sugihara K; Suzuki Y; Watanabe M; Hibi T
    Gastroenterology; 2016 Dec; 151(6):1122-1130. PubMed ID: 27523980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
    Marion JF; Waye JD; Present DH; Israel Y; Bodian C; Harpaz N; Chapman M; Itzkowitz S; Steinlauf AF; Abreu MT; Ullman TA; Aisenberg J; Mayer L;
    Am J Gastroenterol; 2008 Sep; 103(9):2342-9. PubMed ID: 18844620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 18. Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
    Hu AB; Burke KE; Kochar B; Ananthakrishnan AN
    Inflamm Bowel Dis; 2021 May; 27(6):779-786. PubMed ID: 32812048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
    Har-Noy O; Katz L; Avni T; Battat R; Bessissow T; Yung DE; Engel T; Koulaouzidis A; Eliakim R; Ben-Horin S; Kopylov U
    Dig Dis Sci; 2017 Nov; 62(11):2982-2990. PubMed ID: 28965228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.